Susquehanna International Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Susquehanna International Group’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,700	Closed	-$95K	–	14391
2022 Q1	$95K	Buy	+15,700	New	+$95.7K	﹤0.01%	11952
2021 Q2	–	Sell	-13,700	Closed	-$75K	–	13510
2021 Q1	$75K	Buy	+13,700	New	+$67.8K	﹤0.01%	11953
2015 Q2	–	Sell	-445	Closed	-$85K	–	10577
2015 Q1	$85K	Buy	445 +296	+199%	+$68K	﹤0.01%	9017
2014 Q4	$32K	Sell	149 -82	-35%	-$18.3K	﹤0.01%	9443
2014 Q3	$63K	Sell	231 -156	-40%	-$42.4K	﹤0.01%	9177
2014 Q2	$118K	Buy	387 +131	+51%	+$41.6K	﹤0.01%	9364
2014 Q1	$94K	Buy	256 +126	+97%	+$45.7K	﹤0.01%	8579
2013 Q4	$43K	Hold	130	–	–	﹤0.01%	8828
2013 Q3	$56K	Buy	+130	New	+$56.9K	﹤0.01%	8211

Susquehanna International Group's APEN Position: Q2 2023 in Review

Susquehanna International Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 420,511 shares — an estimated $4.17M sold.

Susquehanna International Group first reported a position in APEN in Q1 2014 and held it in 11 quarters. The position peaked at $4.17M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Susquehanna International Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 420,511 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.17M.
Susquehanna International Group first reported a position in Apollo Endosurgery, Inc. in Q1 2014 and held it in 11 quarters.
Susquehanna International Group's Apollo Endosurgery, Inc. position peaked at $4.17M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.